Skip to main content

Table 2 Comparison of baseline data, hematological parameters and coronary angiography data in elevated FBG group and control group

From: Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction

Variables Elevated FBG group (n = 589) Normal FBG group(n = 369) P value
Gender(man) 433 (73.5%) 303 (82.1%) 0.002*
Age 62.91 ± 13.01 61.72 ± 13.84 0.185
Height(cm) 166.77 ± 7.64 166.70 ± 7.20 0.087
Weight(kg) 69.02 ± 12.20 68.15 ± 11.73 0.319
BMI(kg/m2) 24.77 ± 3.70 24.09 ± 3.71 0.012*
SBP(mmHg) 127.08 ± 23.18 125.34 ± 19.14 0.235
DBP(mmHg) 76.89 ± 15.05 76.44 ± 13.84 0.467
Hypertension 349 (59.3%) 202 (54.7%) 0.169
Diabetes 242 (41.1%) 20 (5.4%) < 0.001*
Previous MI 15 (2.5%) 7 (1.9%) 0.514
Cerebral infarction, 86 (14.6%) 16 (4.3%) < 0.001*
CKD 54 (9.2%) 25 (6.8%) 0.190
Smoking 283 (48.0%) 216 (58.5%) 0.002*
Killip grade
 I grade 367 (62.3%) 293 (79.4%) < 0.001*
 II grade 103 (17.5%) 51 (13.8%) 0.133
 III grade 9 (1.5%) 2 (0.5%) 0.163
 IV grade 99 (16.8%) 34 (9.2%) < 0.001*
TNI P50(P25-P75)(ng/ml) 17 (3.98–25) 11 (2.3–25) 0.002*
Myo P50(P25-P75) (ng/ml) 500 (219.75–900) 500 (206.25–900) 0.016*
CK-MB P50(P25-P75)(ng/ml) 80 (36.45–297) 80 (37.5–246.5) 0.260
BNP P50(P25-P75) (pg/ml) 173 (49.75–587.5) 112 (41.45–347.5) 0.001*
WBC (*10^9/L) 12.29 ± 4.45 10.47 ± 2.94 < 0.001*
Hb (g/L) 134.5 ± 23.11 135.99 ± 20.71 0.066
PLT (*10^9/L) 209.87 (160.3–268.3) 201.7 (170.4–259.2) 0.051
RBG(mmol/L) 11.25 (9.3–16.5) 7.22 (6.8–10.0) < 0.001*
ALT P50(P25-P75)IU/L) 48 (33–79) 39 (29–59) < 0.001*
AST P50(P25-P75) (IU/L) 145 (60–219) 171 (89–309) < 0.001*
Scr P50(P25-P75) (μmol/L) 81 (67–98) 80 (72–91) 0.862
eGFR P50(P25-P75)
(ml/min/1.73m2)
80.9 (62.22–97.88) 81.7 (69.2–96.2) 0.704
UA(μmol/L) 376.41 (280.3–390.3.2) 365.35 (249.5–378.4) 0.152
FBG(mmoL/L) 9.79 ± 2.67 5.22 ± 0.52 < 0.001*
TG(mmoL/L) 1.83 (1.28–2.56) 1.64 (0.89–2.06) 0.051
TC(mmoL/L) 4.46 (4.13–5.84) 4.42 (4.02–5.73) 0.667
HDL-c(mmoL/L) 1.12 (0.83–1.46) 1.07 (0.95–1.47) 0.046*
LDL-c(mmoL/L) 2.77 (2.19–3.07) 2.80 (2.26–3.26) 0.682
LVEF (%) 0.53 ± 0.38 0.68 ± 0.34 < 0.001*
Aspirin 581 (98.6%) 364 (98.6%) 0.997
Clopidogrel 61 (10.4%) 55 (14.9%) 0.028*
Ticagrelor 528 (89.6%) 314 (85.1%) 0.028*
ACEI/ARB 277 (47.0%) 205 (55.6%) 0.01*
β-blocker 494 (83.9%) 300 (81.3%) 0.304
Statin 586 (99.5%) 367 (99.5%) 0.946
CCB 30 (5.1%) 30 (8.1%) 0.059
Furosemide 174 (29.5%) 75 (20.3%) 0.002*
Antisterone 172 (29.2%) 77 (20.9%) 0.004*
IABP 51 (8.7%) 12 (3.3%) 0.001*
CABG 10 (17.1%) 3 (0.8%) 0.249
Coronary lesions
 Single vessel lesion 101 (29.0%) 135 (36.6%) < 0.001*
 Double vessel lesions 171(%) 115 (31.2%) 0.483
 Triple vessel lesions 284 (48.2%) 152 (41.2%) 0.034*
Number of stents
 Single stent 340 (57.7%) 242 (65.6%) 0.015*
 Two or more stents 124 (21.1%) 53 (14.4%) 0.009*
 Left main lesion 75 (12.7%) 24 (6.5%) 0.002*